Calliditas Therapeutics AB financial data

Symbol
CALT on Nasdaq
Location
Kungsbron 1, D5, Stockholm, Sweden
State of incorporation
Sweden
Fiscal year end
December 31
Latest financial report
20-F - Q4 2023 - Apr 24, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.6M shares +0.01%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 89M SEK -7.59%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill 48.6M SEK +6.12%
Assets 1.86B SEK -4.8%